KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) has acquired an 80% stake in Symbiotica Speciality Ingredients Sdn Bhd, a leading homegrown active pharmaceutical ingredient (API) manufacturer in South-East Asia (SEA).

Ekuinas chief executive officer Datuk Syed Yasir Arafat Syed Abd Kadir said the pharmaceutical industry is a significant economic contributor with remarkable growth potential.